Pozen, Inc. (POZN) to Host Analyst and Investor Update Webcast
4/10/2013 9:42:37 AM
More...
|
Pozen, Inc. (POZN) Announces Results From a Burden of Cardiovascular Disease Study: a Managed Care Perspective
4/5/2013 9:56:27 AM
More...
|
Pozen, Inc. (POZN) to Present at the 25th Annual ROTH Conference
3/7/2013 6:24:46 AM
More...
|
Pozen, Inc. (POZN) Announces March 6th Webcast of Fourth Quarter and Year End 2012 Results
2/27/2013 6:41:46 AM
More...
|
Pozen, Inc. (POZN) Presents Positive PA32540 Phase 3 Data at the 2013 International Stroke Conference
2/8/2013 9:47:00 AM
More...
|
Pozen, Inc. (POZN) Presents Positive Phase 3 Results
2/8/2013 7:38:08 AM
More...
|
Pozen, Inc. (POZN) Announces Positive Results for the PA8140-102 Bioavailability Study
11/16/2012 9:39:33 AM
More...
|
Pozen, Inc. (POZN) Reports Positive Test Results for Proposed Aspirin Therapy
11/7/2012 7:48:40 AM
More...
|
Pozen, Inc. (POZN) Announces PA32540 Provides Superior Antiplatlet Effects Over a Standard of Care Regimen in a Phase 1 Study ("Co-Rx")
8/29/2012 10:17:54 AM
More...
|
Pozen, Inc. (POZN) Provides Update on Its PA Program and Results of Its Type A Meeting With the FDA
8/24/2012 8:37:50 AM
More...
|
|